CupidQ3 FY22

Cupid Q3 FY22 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹365.85P/E: 290.2Market Cap: ₹49.2K CrSector: Personal Products

Management growth scorecard

Revenue

Category 3

Margin

Category 3

Fundraise

N/A

Order

No

Capex

Yes

1 of 4 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 3
  • Cupid Limited projects a top-line revenue of about Rs. 170 crore for FY23, showing recovery and growth from FY22 levels.
  • Female condom sales are expected to increase significantly, contributing to higher margins and overall profitability.
  • The company aims for a profit after tax of at least Rs. 20 crore in FY23, an improvement over the Rs. 16-17 crore expected in FY22.
  • New manufacturing facility at Nasik expected to start commercial production by April 2022, producing about 9 products including male condoms, female condoms, lubricant jelly, and IVD products.
  • Capacity utilization for male condoms is near 98-100%, indicating strong demand.
  • The company expects gradual growth in the IVD business after regulatory approvals, though precise volume forecasts are yet uncertain.
  • South African government orders (approx. Rs. 100 crore annually) and tender wins in Tanzania (Rs. 75 crore) are expected to drive volume growth.
  • Emphasis on high-margin products and exports for sustained revenue improvement.

See what Cupid management said on margin guidance — free account, 30 seconds.

Fundraise plans

  • There is no mention of any current or planned fundraising through debt or equity in the Q3 FY22 earnings call transcript.
  • The company has about ₹72 crores in cash including mutual funds, FDs, and bank balances.
  • The board is considering a share buyback program but is also evaluating working capital needs for the IVD division before making a final decision.
  • Capital expenditure for the new IVD division is mostly complete with around ₹10 crores spent.
  • No new funding plans through issuance of equity or debt have been disclosed.

See what Cupid management said on order book — free account, 30 seconds.

Capex plans

Yes
  • Cupid Limited has completed its new manufacturing facility at Nasik, with regulatory approvals (ICMR and Drug Controller of India) expected by end of March 2022.
  • The Nasik facility focuses on manufacturing 9 products including male condoms, female condoms, lubricant jelly, and IVD products.
  • Capital expenditure (CAPEX) for the IVD division is mostly complete, with about ₹8 crore spent and an additional ₹2 crore anticipated, totaling ₹10 crore.
  • No current or future large CAPEX beyond this has been specified; the company is cautious with working capital requirements for the IVD business.
  • The management is considering strategic options like a share buyback but is awaiting clearer working capital estimates for the IVD segment before final decisions.

Track Cupid — get its next earnings analysis in your feed

How does Cupid rank vs peers in Personal Products?

Pro feature
ThisCupid
Rev 3Mar 3

How does Cupid rank in Personal Products?

Compare Cupid against every Personal Products company (Q3 FY22) on revenue, margins and earnings-call signals.

View Personal Products leaderboard →

Others in Personal Products this season

  • Anondita Medicare (Q2 FY27)

    Revenue (Standalone)** for H1 FY27: ₹5,786.31 Lakhs, up 21.43% YoY from ₹4,765.06 Lakhs in H1 FY26 . Key investor presentation takeaways from Anondita Medicare

  • Gillette India (Q2 FY27)

    Revenue from operations for the quarter ended 30th September 2026: ₹84,610 lakh (Page 3) . Key results statement takeaways from Gillette India Ltd's Q2 FY27 ear

  • Honasa Consumer (Q2 FY27)

    Younger brands, excluding The Derma Co., are growing healthily at 40%+ year-on-year, with the overall portfolio showing strong momentum across online and…

  • Emami (Q2 FY27)

    Volume growth for domestic business recorded 43% in Q2 and 26% on a like-to-like basis, indicating strong demand. Key concall takeaways from Emami Ltd's Q2…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →